Antiviral Drug Discovery and Development Center - Overall
Antiviral Drug Discovery and Development Center - Overall
批准号:
8641766
负责人:
RICHARD J. WHITLEY
金额:
$627.07万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-03-01 至 2019-02-28
关键词:
AlphavirusAntiviral AgentsChemicalsCoronavirusDevelopmentEvaluationFlavivirusHuman ResourcesInfluenzaLeadMediatingNamesPathway interactionsPharmaceutical ChemistryPolymeraseProductivityResearchResearch Project GrantsScientistTherapeuticTranslational ResearchValidationViralVirus Diseasesdrug candidatedrug developmentdrug discoveryhigh throughput screeningnoveloperationpreclinical evaluationresearch clinical testingscaffoldscreeningsmall moleculesuccess
中文摘要
描述(由申请人提供):本文提出的卓越转化研究中心(CETR)将被命名为抗病毒药物发现和开发中心(AD3C),其中心主题是开发针对新发和再发病毒感染的新小分子疗法。转化研究将集中在病毒复制的抑制,特别是病毒聚合酶。进展途径将包括靶标验证,高通量筛选以确定新的化学支架,以及基础病毒学研究,以证明和进一步探索鉴定的铅分子在病毒复制中的确切作用机制。药物化学和先导物开发活动将沿着药物发现和开发途径推进已确定的化合物,最终导致有希望的候选药物的临床前评估,以进行临床评估。AD3C有四个相互关联的研究项目,重点是黄病毒、冠状病毒、甲病毒和流感。它们的工作将得到三个核心的支持:行政核心(核心A);
英文摘要
DESCRIPTION (provided by applicant): The herein proposed Center of Excellence for Translational Research (CETR), which will be named the Antiviral Drug Discovery and Development Center (AD3C) has, at its center, the theme to develop new small molecule therapeutics for emerging and re-emerging viral infections. Translational research will focus on the inhibition of viral replication, especially viral polymerases. Progression pathways will includ target validation, high throughput screening to identify novel chemical scaffolds, and basic virologic research to prove and further probe the exact mechanism of action of identified lead molecules in viral replication. Medicinal chemistry and lead development activities will advance identified compounds down the drug discovery and development pathway, ultimately leading to preclinical evaluation of promising drug candidates for clinical evaluation. The AD3C has four interrelated research projects with a focus on flaviviruses, coronaviruses, alphaviruses and influenza. They will be supported in their efforts by three cores: an Administrative Core (Core A),
a Screening Core (SC; Core B) and a Medicinal Chemistry and Lead Development Core (MCLDC; Core C). Organization and interaction between all projects and cores will be mediated out of the Administrative Core, with day to day AD3C operations led by the Core's personnel. An Executive Committee (EC) consisting of all project and core leaders will regularly review the projects' and cores' activities and productivity. Finally, an External Scientific Advisory Board (EAB) of distinguished scientists has been established to annually provide a high level evaluation of AD3C's progress and successes, and aid in refining the Center's activities and direction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 4 - Influenza - UAB
-
批准号:10380669
-
项目类别:
-
资助金额:$93.75万
-
财政年份:2019
-
负责人:RICHARD J. WHITLEY
-
依托单位:
Antiviral Drug Discovery and Development Center (AD3C)
-
批准号:9888306
-
项目类别:
-
资助金额:$750.0万
-
财政年份:2019
-
负责人:RICHARD J. WHITLEY
-
依托单位:
Antiviral Drug Discovery and Development Center (AD3C)
-
批准号:10115578
-
项目类别:
-
资助金额:$750.0万
-
财政年份:2019
-
负责人:RICHARD J. WHITLEY
-
依托单位:
Project 4 - Influenza - UAB
-
批准号:10115602
-
项目类别:
-
资助金额:$88.85万
-
财政年份:2019
-
负责人:RICHARD J. WHITLEY
-
依托单位:
Administrative Core
-
批准号:10380661
-
项目类别:
-
资助金额:$93.75万
-
财政年份:2019
-
负责人:RICHARD J. WHITLEY
-
依托单位:
Project 4 - Influenza - UAB
-
批准号:10580026
-
项目类别:
-
资助金额:$87.22万
-
财政年份:2019
-
负责人:RICHARD J. WHITLEY
-
依托单位:
Administrative Core
-
批准号:10580017
-
项目类别:
-
资助金额:$18.23万
-
财政年份:2019
-
负责人:RICHARD J. WHITLEY
-
依托单位:
Antiviral Drug Discovery and Development Center (AD3C)
-
批准号:10380660
-
项目类别:
-
资助金额:$750.0万
-
财政年份:2019
-
负责人:RICHARD J. WHITLEY
-
依托单位:
Pilot and Feasibility Core
-
批准号:10465122
-
项目类别:
-
资助金额:$9.96万
-
财政年份:2019
-
负责人:RICHARD J. WHITLEY
-
依托单位:
Pilot and Feasibility Core
-
批准号:10001434
-
项目类别:
-
资助金额:$7.72万
-
财政年份:2019
-
负责人:RICHARD J. WHITLEY
-
依托单位:
Pilot and Feasibility Core
-
批准号:10248361
-
项目类别:
-
资助金额:$12.37万
-
财政年份:2019
-
负责人:RICHARD J. WHITLEY
-
依托单位:
Administrative Core
-
批准号:10115588
-
项目类别:
-
资助金额:$18.96万
-
财政年份:2019
-
负责人:RICHARD J. WHITLEY
-
依托单位:
Antiviral Drug Discovery and Development Center (AD3C)
-
批准号:10580015
-
项目类别:
-
资助金额:$750.0万
-
财政年份:2019
-
负责人:RICHARD J. WHITLEY
-
依托单位:
Identification and characterization of novel drugs that target the Influenza
-
批准号:9217553
-
项目类别:
-
资助金额:$104.47万
-
财政年份:2014
-
负责人:RICHARD J. WHITLEY
-
依托单位:
Administrative Core
-
批准号:8299605
-
项目类别:
-
资助金额:$9.81万
-
财政年份:2011
-
负责人:RICHARD J. WHITLEY
-
依托单位:
Preclinical Evaluation of Oncolytic HSV for Anaplastic Glioma Therapy
-
批准号:8299603
-
项目类别:
-
资助金额:$17.2万
-
财政年份:2011
-
负责人:RICHARD J. WHITLEY
-
依托单位:
Preclinical Evaluation of Oncolytic HSV for Anaplastic Glioma Therapy
-
批准号:7747230
-
项目类别:
-
资助金额:$17.76万
-
财政年份:2009
-
负责人:RICHARD J. WHITLEY
-
依托单位:
Administrative Core
-
批准号:7747238
-
项目类别:
-
资助金额:$10.12万
-
财政年份:2009
-
负责人:RICHARD J. WHITLEY
-
依托单位:
Development of Antiviral Screens and Animal Models
-
批准号:7652105
-
项目类别:
-
资助金额:$42.16万
-
财政年份:2008
-
负责人:RICHARD J. WHITLEY
-
依托单位:
BIOLOGIC CHARACTERIZATION OF ENGINEERED HSV FOR THERAPY OF BRAIN TUMORS
-
批准号:6502917
-
项目类别:
-
资助金额:$20.68万
-
财政年份:2001
-
负责人:RICHARD J. WHITLEY
-
依托单位:
海外基金